# An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet

> **NCT05450575** · — · COMPLETED · sponsor: **Hanmi Pharmaceutical Company Limited** · enrollment: 5400 (actual)

## Conditions studied

- Hypertension
- Dyslipidemia

## Interventions

- **DRUG:** Amosartan Q tablet

## Key facts

- **NCT ID:** NCT05450575
- **Lead sponsor:** Hanmi Pharmaceutical Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-17
- **Primary completion:** 2021-07-20
- **Final completion:** 2021-07-20
- **Target enrollment:** 5400 (ACTUAL)
- **Last updated:** 2022-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05450575

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05450575, "An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT05450575. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*